NC
MDT icon

NovaPoint Capital’s Medtronic MDT Stock Holding History

NovaPoint Capital’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.82M Buy
48,884
+4,828
+11% +$389K 0.8% 42
2026
Q1 		$3.82M Buy
44,056
+2,930
+7% +$281K 0.96% 47
2025
Q4 		$3.95M Buy
41,126
+1,286
+3% +$125K 1.02% 43
2025
Q3 		$3.79M Buy
39,840
+4,650
+13% +$427K 0.93% 42
2025
Q2 		$3.07M Buy
35,190
+2,114
+6% +$179K 0.94% 44
2025
Q1 		$2.97M Buy
33,076
+591
+2% +$52.9K 0.92% 45
2024
Q4 		$2.59M Buy
32,485
+1,233
+4% +$107K 0.79% 48
2024
Q3 		$2.81M Buy
31,252
+1,734
+6% +$146K 0.87% 46
2024
Q2 		$2.32M Buy
29,518
+1,007
+4% +$82.6K 0.79% 49
2024
Q1 		$2.48M Sell
28,511
-2,542
-8% -$217K 0.87% 45
2023
Q4 		$2.56M Sell
31,053
-1,580
-5% -$120K 0.95% 45
2023
Q3 		$2.56M Buy
32,633
+1,953
+6% +$163K 1.02% 41
2023
Q2 		$2.7M Sell
30,680
-370
-1% -$31.9K 1.01% 39
2023
Q1 		$2.5M Buy
31,050
+1,728
+6% +$141K 1.03% 39
2022
Q4 		$2.28M Buy
29,322
+1,362
+5% +$110K 1% 45
2022
Q3 		$2.26M Buy
27,960
+568
+2% +$51K 1.03% 41
2022
Q2 		$2.46M Buy
27,392
+1,914
+8% +$194K 1.07% 38
2022
Q1 		$2.83M Buy
25,478
+1,567
+7% +$166K 1.03% 43
2021
Q4 		$2.47M Buy
23,911
+3,126
+15% +$362K 0.89% 45
2021
Q3 		$2.6M Buy
20,785
+146
+0.7% +$18.9K 1.05% 38
2021
Q2 		$2.56M Buy
20,639
+787
+4% +$98.8K 1.06% 41
2021
Q1 		$2.35M Sell
19,852
-95
-0.5% -$11.1K 1.1% 42
2020
Q4 		$2.34M Buy
19,947
+3,665
+23% +$403K 1.22% 37
2020
Q3 		$1.69M Buy
16,282
+1,358
+9% +$136K 1.1% 40
2020
Q2 		$1.37M Buy
14,924
+930
+7% +$89.2K 1.02% 43
2020
Q1 		$1.26M Buy
13,994
+4
+0% +$426 1.15% 33
2019
Q4 		$1.59M Buy
+13,990
New +$1.54M 1.24% 41

Other funds holding MDT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

NovaPoint Capital's MDT Position: Q2 2026 in Review

NovaPoint Capital increased its Medtronic (MDT) stake by 11% in Q2 2026, buying an estimated $389K and bringing the position to 48,884 shares worth $3.82M. The position accounts for 0.8% of the portfolio, ranked #42.

NovaPoint Capital first reported a position in MDT in Q4 2019 and has held it in 27 quarters since. The position peaked at $3.95M in Q4 2025. 2,134 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • NovaPoint Capital held 48,884 shares of Medtronic worth $3.82M as of Q2 2026.
  • NovaPoint Capital bought 4,828 Medtronic shares in Q2 2026, an estimated $389K.
  • Medtronic made up 0.8% of NovaPoint Capital's portfolio in Q2 2026, its #42 holding.
  • NovaPoint Capital first reported a position in Medtronic in Q4 2019 and has held it in 27 quarters since.
  • NovaPoint Capital's Medtronic position peaked at $3.95M in Q4 2025.
  • 2,134 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on NovaPoint Capital's 13F filing for Q2 2026, filed 6 Aug 2026.